← Back to CoursesMolecular Neuroscience: Intermediate

Neuroanatomy Explorer

Drag to rotate · scroll to zoom · click regions to explore

View
Loading 3D model…

Click a region
to explore it

Memory Deck

Flip each card and rate whether you knew it. Your score is saved.

Term
Definition

Deck complete — score saved.

Match the Pairs

Match each term to its definition. Finish the board to earn your score.

All matched — score saved.

Concept Constellation

Every key idea in this course, mapped as an explorable 3D constellation. Drag to rotate, scroll to zoom, click a node.

Click a node to read its definition.

Molecular Basis of Neurological Disease

Manual: General · Subject: Molecular Neuroscience

Link molecular defects to disorders of synaptic function, neurodevelopment, degeneration, and inflammation.

From Molecule to Disease

Disease Logic

Many neurological disorders arise when molecular components of neurons or glia fail. Mutations, misfolded proteins, impaired trafficking, excitotoxicity, and abnormal immune signaling can all disrupt neural circuits.

Common Mechanistic Themes

Channelopathies
Diseases caused by ion channel dysfunction
Synaptopathies
Conditions involving abnormal synaptic proteins or signaling
Protein aggregation
Pathological buildup of misfolded proteins
Neuroinflammation
Maladaptive immune signaling in the nervous system
⚠️

Clinical Thinking

The same molecular defect can produce different symptoms depending on where, when, and in which cell type it occurs.

What is a channelopathy?

What is one molecular process that can contribute to neurodegeneration?

Excitotoxicity and Vulnerability

Excessive glutamatergic stimulation can overactivate receptors, raise intracellular calcium, and trigger damaging enzymatic cascades. Vulnerability depends on receptor composition, energy status, and antioxidant defenses.

Major Disease Mechanisms

Loss of function

  • Reduced protein activity
  • Common in receptor or enzyme defects

Gain of toxic function

  • Abnormal harmful activity
  • Common in aggregation disorders

Mechanistic Pathway to Disease

  1. 1

    Step 1: A gene mutation or environmental insult alters a molecule.

  2. 2

    Step 2: Protein function, trafficking, or signaling is disrupted.

  3. 3

    Step 3: Synapses, cells, or circuits become abnormal.

  4. 4

    Step 4: Symptoms emerge at the behavioral level.

  5. 5

    Step 5: Intervention targets the disrupted mechanism.

Why can the same mutation have different clinical outcomes across cell types?

Name one broad class of molecules often targeted in neurological disease therapy.